Corbus Pharmaceuticals Holdings, Inc. (CRBP) Operating cash flow 2016–2025
Corbus Pharmaceuticals Holdings, Inc. (CRBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$64.5MFY2025 · since FY2016: -$13.6M → -$64.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$64.5M | -54.3% |
| FY2024 | -$41.8M | -15.8% |
| FY2023 | -$36.1M | +3.8% |
| FY2022 | -$37.5M | +22.1% |
| FY2021 | -$48.2M | +51.7% |
| FY2020 | -$99.7M | -118.0% |
| FY2019 | -$45.7M | -52.1% |
| FY2018 | -$30.1M | -8.2% |
| FY2017 | -$27.8M | -104.8% |
| FY2016 | -$13.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CRBP financial trends
CRBP RevenueCRBP Net incomeCRBP Net marginCRBP Gross profitCRBP Gross marginCRBP Operating incomeCRBP Operating marginCRBP Free cash flowCRBP Capital expendituresCRBP Return on equityCRBP Stock buybacksCRBP Dividends paidCRBP Total assetsCRBP Total liabilitiesCRBP Shareholders’ equityCRBP overview →